What's Happening?
Saku Biosciences, a Los Angeles-based startup, is pioneering a new approach in biomanufacturing by using tiny porous 'PicoShells' to encapsulate cells. This method aims to improve the high-throughput screening
process by better mimicking real-world fermentation environments. The PicoShells allow nutrients and oxygen to enter while keeping waste out, thus maintaining the separation of each cell colony. This innovation addresses the common issue of false positives and negatives in traditional screening methods, which often do not translate well to bioreactor systems. Saku Biosciences has recently secured venture capital funding from Big Idea Ventures to further develop this technology, which emerged from research at UCLA.
Why It's Important?
The development of PicoShells by Saku Biosciences could significantly impact the biomanufacturing industry by reducing the time and cost associated with developing optimized production hosts. This technology has the potential to enhance the economic viability of producing various bioproducts, such as dairy proteins and biopesticides, by identifying better-performing strains that can thrive in real-world conditions. By improving the efficiency of the screening process, Saku Biosciences aims to help companies scale production more rapidly and economically, which could lead to broader adoption of biomanufacturing techniques across industries.
What's Next?
Saku Biosciences plans to move from academic validation to early customer contracts, focusing on industries such as pharmaceuticals, agriculture, and industrial biotechnology. The company is also exploring a two-pronged business model, offering both a service/partnership model and developing off-the-shelf starter strains with better baseline economics. As the technology gains traction, it could lead to more efficient and cost-effective biomanufacturing processes, potentially transforming the industry landscape.
